What was Nanoform Finland Oyj’s price range in the past 12 months?
Nanoform Finland Oyj lowest stock price was kr 4.15 and its highest was kr 13.22 in the past 12 months.
What is Nanoform Finland Oyj’s market cap?
Nanoform Finland Oyj’s market cap is kr 709.45M.
When is Nanoform Finland Oyj’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Nanoform Finland Oyj’s earnings last quarter?
Nanoform Finland Oyj released its earnings results on Nov 19, 2026. The company reported -kr 0.369 earnings per share for the quarter, missing the consensus estimate of -kr 0.336 by -kr 0.034.
Is Nanoform Finland Oyj overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Nanoform Finland Oyj pay dividends?
Nanoform Finland Oyj does not currently pay dividends.
What is Nanoform Finland Oyj’s EPS estimate?
Nanoform Finland Oyj’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Nanoform Finland Oyj have?
Nanoform Finland Oyj has 85,754,850 shares outstanding.
What happened to Nanoform Finland Oyj’s price movement after its last earnings report?
Nanoform Finland Oyj reported an EPS of -kr 0.369 in its last earnings report, missing expectations of -kr 0.336. Following the earnings report the stock price went down -13.504%.
Which hedge fund is a major shareholder of Nanoform Finland Oyj?
Currently, no hedge funds are holding shares in SE:NANOFS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Nanoform Finland Oyj
Helsinki, Finland-based Nanoform Finland Oyj provides advanced nanotechnology and drug particle engineering solutions for the pharmaceutical sector across Europe and the United States. The company specializes in the production of nanoparticles, utilizing its exclusive "controlled expansion of supercritical solutions" technology, which aids its clients in their development processes. Nanoform was established in 2008.